Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen

NCT00615589 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Multiple Myeloma
Plasma Cell Leukemia

Interventions

DRUG: Fludarabine/Busulfan x 4 days
PROCEDURE: stem cell transplant

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]